Literature DB >> 21552409

Mucinous carcinoma of breast: Cytodiagnosis of a case.

Sangeeta Sharma1, Rani Bansal, Anjali Khare, Nivesh Agrawal.   

Abstract

Mucinous carcinoma of the breast is a relatively rare, pure form accounting for 2% of all breast cancers. Pure mucinous carcinoma of the breast has a favorable prognosis. The common age is postmenopausal group. Here, we report a 30-year-old female patient diagnosed on cytology as mucinous carcinoma of the breast with lymph node metastasis and subsequently confirmed by histopathology. In 1 year follow-up, the patient did not show pulmonary or distant metastasis and received adjuvant chemotherapy at every 3 weeks interval.

Entities:  

Keywords:  Breast; fine needle aspiration cytology; mucinous carcinoma

Year:  2011        PMID: 21552409      PMCID: PMC3083536          DOI: 10.4103/0970-9371.76952

Source DB:  PubMed          Journal:  J Cytol        ISSN: 0970-9371            Impact factor:   1.000


Introduction

Mucinous carcinoma of the breast is uncommon, the reported incidence of pure mucinous carcinoma being 2% of all breast cancers.[12] Traditionally, pure and mixed variants of mucinous carcinoma have been described.[23] Pure mucinous carcinoma has a far better prognosis than the mixed variety noted in several studies.[23] We report a case diagnosed as pure mucinous carcinoma breast on fine needle aspiration cytology (FNAC) in a female of reproductive age group.

Case Report

A 30-year-old female presented with a large firm lump in upper quadrant of right breast for 4 years, which was gradually increasing in size and was associated with pain. The mass measured 10×10 cm and was fixed to the underlying structures. The overlying skin was normal and nipple was not retracted. No axillary lymph node was palpable. The clinical diagnosis of carcinoma right breast was made. FNAC of mass was advised.

Pathological findings

Fine needle aspiration was done from right breast mass. Smears showed abundant pink mucoid material. There were numerous moderately pleomorphic epithelial cells lying either discretely forming loose clusters or entrapped within stromal material [Figure 1]. At places, the cells were forming tubular structures. Mitotic figures were also seen. The cytological findings were suggestive of mucus secreting carcinoma. The patient underwent a radical mastectomy with axillary lymph node clearance.
Figure 1

FNAC smear showing abundant pink mucoid material (arrow) with entrapped tumor cells (arrow head) (H and E, ×400)

FNAC smear showing abundant pink mucoid material (arrow) with entrapped tumor cells (arrow head) (H and E, ×400) Right mastectomy specimen with axillary tail measuring 20 cmΧ14 cmΧ4 cm was received. Overlying skin measured 20 cmΧ11 cm, and the axillary tail measured 9 cm×6 cm×2 cm. Cut surface revealed circumscribed mass with variegated appearance, grey brown in color, and solid to cystic with areas of necrosis and hemorrhage. Tumor mass measured 7 cm×6 cm×5 cm, and extended from subepidermal tissue to posterior resected margin. Four lymph nodes were identified in axillary tail, with the largest measuring 3 cm×2 cm×1 cm and the smallest measuring 1 cm×0.5 cm×0.5 cm. Cut surface of the largest was gelatinous and necrotic. Three axillary lymph nodes with fibrofatty tissue received separately ranged from 0.5 to 1.5 cm, and had unremarkable cut surface. Sections from different areas of specimen were studied. Sections from tumor mass revealed large areas of necrosis, myxoid degeneration and lakes of mucoid material [Figure 2]. The tumor cells were round to polyhedral, exhibiting mild pleomorphism but frequent mitotic figures. These cells were mostly arranged in thin trabeculae, single rows and few solid cellular areas. Stroma was delicate in the form of fibrous bands. At places, tubular and cribriform patterns were present. Adjacent breast tissue showed suppurative inflammatory reaction. Tumor was reaching close to posterior resected margin but was separated by a thin rim of uninvolved fibroadipose tissue. All other resected margins were free. Microscopically, seven lymph nodes were identified of which the largest was almost completely replaced by tumor metastasis. Other lymph nodes showed non-specific reactive lymphoid and sinusoidal hyperplasia. Histopathological diagnosis of mucinous carcinoma (cellular variant) was given. Tumor tissue was negative for estrogen receptor (ER) and progesterone receptor (PR).
Figure 2

Section showing lakes of mucoid material (arrow) with enmeshed column of tumor cells (arrow head) (H and E, ×400)

Section showing lakes of mucoid material (arrow) with enmeshed column of tumor cells (arrow head) (H and E, ×400)

Discussion

Mucinous carcinoma of the breast is an uncommon entity seen in postmenopausal females, accounting for only 2% of all breast carcinomas.[12] However, we are reporting a case of mucinous carcinoma in a young female aged 30 years. The behavior of the tumor tends to be less aggressive, so it has a better prognosis than other breast malignancies. The pure mucinous carcinomas are further subdivided into cellular and hypocellular variants. As soon as another pattern becomes evident as a component of tumor mass, the lesion qualifies as a mixed tumor. The most common admixture is with regular invasive duct carcinoma. Our case was the cellular variant of pure mucinous carcinoma breast. Two lesions most likely to be confused with mucinous carcinoma are mucoid fibroadenoma and mucocele like lesion.[4] Mucinous carcinoma is ER positive, and in less than 70% cases, it is PR positive.[56] However, in our case, it was both ER and PR negative. Nearly all pure mucinous carcinomas are diploid, while over 50% of mixed variety is aneuploid. Only 3–15% of pure variety shows axillary node metastasis compared to 33–46% of the mixed type.[37] In the present case, one axillary node was positive for tumor deposits. Late distant metastases may occur.[28] The present case did not show any distant metastasis either at the time of diagnosis or during the 1 year of follow-up. Adjuvant chemotherapy containing cyclophosphamide, adriamycin and 5 fluorouracil (5 FU) was given at every 3 weeks interval. Histochemically, the mucins secreted by this tumor are distinct O-acylated forms of sialomucin.[9] Immunohistochemically, there is strong MUC (mucin) 2 cytoplasmic immunoreactivity and decreased MUC I immunoreactivity compared with ductal carcinoma not otherwise specified (NOS). One-fourth to nearly one-half shows features consistent with endocrine differentiation.[10]

Conclusion

We have reported a case of pure mucinous carcinoma in a young female emphasizing the role of FNAC in its early diagnosis.
  10 in total

1.  Mucinous carcinoma of the breast in Japan. A prognostic analysis based on morphologic features.

Authors:  K Komaki; G Sakamoto; H Sugano; T Morimoto; Y Monden
Journal:  Cancer       Date:  1988-03-01       Impact factor: 6.860

2.  Mucinous (colloid) adenocarcinomas secrete distinct O-acylated forms of sialomucins: a histochemical study of gastric, colorectal and breast adenocarcinomas.

Authors:  C Sáez; M A Japón; M A Poveda; D I Segura
Journal:  Histopathology       Date:  2001-12       Impact factor: 5.087

3.  Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas.

Authors:  S G Diab; G M Clark; C K Osborne; A Libby; D C Allred; R M Elledge
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

4.  Pure mucinous carcinomas of breast: morphologic features and prognostic correlates.

Authors:  F Clayton
Journal:  Hum Pathol       Date:  1986-01       Impact factor: 3.466

5.  Pathological features of mucinous carcinoma of the breast are favourable for breast-conserving therapy.

Authors:  K Anan; S Mitsuyama; K Tamae; K Nishihara; T Iwashita; Y Abe; T Ihara; S Nakahara; F Katsumoto; S Toyoshima
Journal:  Eur J Surg Oncol       Date:  2001-08       Impact factor: 4.424

6.  Mucocele-like tumors of the breast.

Authors:  P P Rosen
Journal:  Am J Surg Pathol       Date:  1986-07       Impact factor: 6.394

7.  Solid and mucinous varieties of so-called mammary carcinoid tumors.

Authors:  E R Fisher; A S Palekar
Journal:  Am J Clin Pathol       Date:  1979-12       Impact factor: 2.493

8.  Pure and mixed mucinous carcinomas of the breast: a clinicopathologic analysis of 61 cases with long-term follow-up.

Authors:  S Toikkanen; H Kujari
Journal:  Hum Pathol       Date:  1989-08       Impact factor: 3.466

9.  Oestrogen receptors in mucinous carcinoma of the breast: an immunohistological study using paraffin wax sections.

Authors:  S Shousha; A T Coady; T Stamp; K R James; J Alaghband-Zadeh
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

10.  Mucinous carcinoma of the breast. A clinicopathologic, histochemical, and immunocytochemical study with special reference to neuroendocrine differentiation.

Authors:  L Scopsi; S Andreola; S Pilotti; R Bufalino; M T Baldini; A Testori; F Rilke
Journal:  Am J Surg Pathol       Date:  1994-07       Impact factor: 6.394

  10 in total
  6 in total

1.  A Case of Pure Mucinous Breast Carcinoma in a 25-Year-Old Female Who Showed Complete Pathological Response to Neoadjuvant Chemotherapy despite Poor Clinical Response.

Authors:  Pei Du; Chunjie Hou; Jinglan Tang; Ying Liu; Qiaohong Hu; Hongfeng He; Kefeng Lu; Lucou Chen
Journal:  Breast Care (Basel)       Date:  2019-12-12       Impact factor: 2.860

2.  A cytomorphological study of secretions in breast cancer.

Authors:  Arati Bhatia; Geetu Malhotra; Punita Grover; Navjeevan Singh
Journal:  J Cytol       Date:  2011-10       Impact factor: 1.000

3.  Mucinous carcinoma of the male breast with axillary lymph node metastasis: Report of a case based on fine needle aspiration cytology.

Authors:  Anjali P Ingle; Anjali S Kulkarni; Sunita P Patil; Neela R Kumbhakarna; Rajan S Bindu
Journal:  J Cytol       Date:  2012-01       Impact factor: 1.000

4.  Gray Lesions of the Breast and its Diagnostic Significance: A Retrospective Study from Rural India.

Authors:  Seema Dayal; Mani Krishna; Sanjay Kumar Kannaujia; Seema Singh
Journal:  J Microsc Ultrastruct       Date:  2021-01-22

5.  Pure mucinous breast carcinoma in a 25-year-old female, a case report.

Authors:  Irean Garcia-Hernandez; Carlos A Lopez-Garcia; Servando Cardona-Huerta; Rocio Ortiz-Lopez; Nydia Paulina Herrera-Rios; B Kanagusico-Elguezabal; Esteban-Zubero Eduardo; Gabriela Sofia Gomez-Macias
Journal:  Int J Surg Case Rep       Date:  2018-10-17

Review 6.  HER2-positive pure mucinous breast carcinoma: A case report and literature review.

Authors:  Xingjuan Zhao; Xuan Yang; Runfang Gao; Liqin Zhai; Lizhu Yang; Keda Yu
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.